Who are Lapine T-Lymphocyte Immune Globulin's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): rabbit anti-thymocyte globulin - 4 doses, Anti-Thymocyte Globulins, Anti-Human Thymocyte Immunoglobulin, Rabbit, Thymoglobulin (ATG), Anti-human Thymoglobulin, Rabbit ATG, (Genzyme).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/lapine-t-lymphocyte-immune-globulin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Lapine T-Lymphocyte Immune Globulin — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lapine T-Lymphocyte Immune Globulin (Lapine T-Lymphocyte Immune Globulin) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antithymocyte globulin (ATG). Area: Immunology, Hematology, Transplantation.

phase 3 Antithymocyte globulin (ATG) T lymphocyte surface antigens Immunology, Hematology, Transplantation Biologic Live · refreshed every 30 min

Target snapshot

Lapine T-Lymphocyte Immune Globulin (Lapine T-Lymphocyte Immune Globulin) — M.D. Anderson Cancer Center. Lapine T-lymphocyte immune globulin depletes T lymphocytes to suppress immune rejection and graft-versus-host disease.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Lapine T-Lymphocyte Immune Globulin TARGET	Lapine T-Lymphocyte Immune Globulin	M.D. Anderson Cancer Center	phase 3	Antithymocyte globulin (ATG)	T lymphocyte surface antigens
rabbit anti-thymocyte globulin - 4 doses	rabbit anti-thymocyte globulin - 4 doses	University of Nebraska	marketed	Polyclonal antithymocyte antibody	T lymphocyte surface antigens (CD2, CD3, CD4, CD8, HLA-DR)
Anti-Thymocyte Globulins	Anti-Thymocyte Globulins	Tianjin First Central Hospital	marketed	Polyclonal antibody; immunosuppressant	T lymphocyte surface antigens (CD2, CD3, CD4, CD8, and other T cell markers)
Anti-Human Thymocyte Immunoglobulin, Rabbit	Anti-Human Thymocyte Immunoglobulin, Rabbit	Peking Union Medical College Hospital	marketed	Polyclonal antithymocyte immunoglobulin	Human thymocytes and T lymphocyte surface antigens (CD2, CD3, CD4, CD8, HLA-DR)
Thymoglobulin (ATG)	Thymoglobulin (ATG)	M.D. Anderson Cancer Center	marketed	Polyclonal antithymocyte globulin (ATG)	Multiple T-cell antigens (CD2, CD3, CD4, CD8, CD11a, CD18, CD25, HLA-DR)
Anti-human Thymoglobulin	Anti-human Thymoglobulin	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	marketed	Polyclonal antithymocyte globulin (ATG)	T-cell surface antigens (CD2, CD3, CD4, CD8, HLA-DR)
Rabbit ATG, (Genzyme)	Rabbit ATG, (Genzyme)	Jinan Military General Hospital	marketed	Polyclonal antithymocyte globulin (ATG)	T-cell surface antigens (CD2, CD3, CD4, CD8, HLA-DR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antithymocyte globulin (ATG) class)

M.D. Anderson Cancer Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Lapine T-Lymphocyte Immune Globulin — Competitive Intelligence Brief. https://druglandscape.com/ci/lapine-t-lymphocyte-immune-globulin. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab